MUC4(68%), MUC16(45%), PIK3CA(36%), TTN(31%), TP53(30%), NBPF10(30%), NBPF1(29%), CDC27(26%), AHNAK2(24%), and MUC2(22%) were the top mutated genes in our breast cancer cohort. This evidence concerns the gene MUC16 and breast carcinoma.